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BACTERIOLOGISTS have long used assays based on a dilution series to estimate
the number of organisms in water (see for example, Cruickshank, 1960). The
same principle has recently been applied to the assay ofcells in certain mammalian
tumours (Hewitt, 1958; Silini and Hornsey, 1961; Berry and Andrews, 1961).
Serial dilutions ofa suspension oftumour cells are injected into groups ofanimals,
and the development of a tumour in a recipient animal implies that the inoculum
contained at least one reproductively intact cell. Recipient animals for such
assays are more expensive than the tubes ofnutrient broth used by bacteriologists,
and the supply of highly-inbred animals is usually the limiting factor on the
amount of experimentation possible: hence it is reasonable to enquire how the
best use may be made of a limited number of assay animals. An inefficient
statistical method will of course waste information, and this is discussed in Ap-
pendix A.
METHODS
In this discussion the term " dose " is reserved for the number of morpho-
logically typical tumour cells injected into a recipient animal. A reproductively
intact cell is one that is capable of forming a tumour in the recipient. If a well-
stirred suspension of cells is used and there is no clumping, the number of repro-
ductively intact cells will follow a Poisson distribution (as pointed out by Hewitt,
1958): that is, the chance of no tumour developing is e-x, where x is the mean
number of intact cells per " dose ". For example: if a dose containing on
average 3 morphologically typical tumour cells were given to each of 100 animals,
and if 37 of these failed to develop tumours, then the mean number of repro-
ductively intact cells per " dose " would be estimated as the solution ofe-x = 0-37:
in this case x - 1. This would imply that about one in three of the morpho-
logically typical tumour cells used were in fact reproductively intact.
An experimental assay will normally use several different " doses ", each in-
jected into a group ofassay animals: the problem becomes that of combining the
information from all the groups, into one estimate of the proportion of tumour
cells that are reproductively intact. Finney (1952) has discussed the maximum
likelihood solution of this problem, using the ingenious device of an equivalent
deviate. He points out that ifan estimate is sought ofthe logarithm ofthe numberE. H1. PORTER AND R. J. BERRY
of intact cells per "dose ", the analysis is simplified,* and the distribution of
errors becomes more nearly normal. This manoeuvre is also convenient for
studies of radiation and drug toxicity, where interest centres on the logarithm
of a surviving fraction (i.e. on the logarithm of the intact proportion after treat-
ment, minus the logarithm of the intact proportion of untreated control cells).
A computational method will be presented here for the maximum likelihood
analysis of this type of assay. It is a modification of Finney's method (see note
to Appendix B, Table II); and the logical and mathematical justification will be
found in Finney's masterly treatise (1952). An iterative process is necessary:
from an initial estimate of the logarithm of the proportion of intact cells we
obtain a better second estimate; this second estimate may be used to form an
even better third estimate, and so on until the successive estimates differnegligibly,
and the solution has been closely approached. In practice a judicious first
estimate will often lead, after only one iterative cycle, to an adequate approxima-
tion; more than two cycles will only be needed if the first choice proves ill-
judged, or if the data are very irregular.
The calculations
For each " dose "we tabulate:
(i) The " dose" in morphologically typical cells per assay animal.
(ii) n: the number of animals given this " dose ".
(iii) r: the number of animals responding (i.e. developing tumours).
(iv) q r/n: the proportion of animals responding at this " dose ".
(v) Y: the initial estimate of log (number of intact cells per " dose ").
A method of forming the initial estimates for the Y column will be discussed
later, but it will be obvious that once Y is established for any one " dose ", all
the remaining Y's will be fixed by the relationship between the various " doses ".
Thus, if for a " dose " of 10 morphologically typical cells the initial estimate of
Y were 0-0, then for a " dose " of 40 cells the initial estimate of Y would have to
be +0-6 (adding the difference between log 40 and log 10).
Two further columns are tabulated for the first cycle:
(vi) nw: the weight. This is the product of n (from column (i)), and w which
depends only on Y, and is tabulated against Y in Appendix B, Table II.
(vii) 0 : the correction deviate. This measures the extent to which the data
for each "dose" disagree with the theory about the number of intact
cells per "dose'" expressed by the Y column. Consequently it depends
both on Y and on q, and may be found from the relationship:
* If the proportion of cells which are reproductively intact is E, and a
" dose
" of z morpho-
logically typical cells is given, the chance of no tumour developing is P = e-E:, from the Poisson
distribution. An estimate of P is given by p, the observed proportion of tumour-free animals.
Now taking natural logarithms twice, we may define Y as:
Y log (-log P)
so that:
Y - log E + log z
aind we may also define y as log (- log p). The advantage of this transformation is that it makes
the relationship linear in log z. We could proceed by fitting a straight line of unit slope to the y's,
plotted against log z, but because the slope of this line is fixed the calculation can be rearranged so
that only a weighted mean need be evaluated. If we wish for the maximum likelihood solution
(which is known to give, in a certain sense, the most efficient estimate) an iterative process is needed,
such as the process to be described in the text.
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The quantities 5b and A are tabulated against Y in Appendix B, Table II,
which also gives 51, the value assumed by q when q = 1 (i.e. when all animals
tested at this " dose " respond).
The first iterative cycle ends with the calculation of a weighted mean of the
0's, which may be expressed (following Finney's use of the symbol S to signify
summation) as:
Snwo
Snw
The sum of the weights, Snw, and the algebraic sum of products Snwq can be
accumulated conveniently on a desk calculator, but a slide-rule will suffice for the
formation of +.
This mean correction 4, is added to each of the Y's to give a new Y column,
with which the next cycle can begin. When 4 becomes satisfactorily small,
iteration can cease and two relationships now hold:
(1) The variance of + is given by 1/Snw, and this is hence also the variance
of the final estimate of the logarithm of the proportion of morphologically typical
cells that are reproductively intact. This estimate will be symbolised by log E.
(2) An inconsistency x2 can be rapidly calculated after a column has been
formed of the squares of the individual 0 values. It is given by:
x2 _SnWO2 (Snwo)2 x -nwq2 - nw_
and has degrees of freedom one less than the number of " doses ". If this x2 is
significant, it is evidence of internal inconsistency in the assay: the formula is
easier than calculation ofexpected numbers to compare with the observed ones.
An example of the calculations
The data shown in Table I were accumulated over several months: considera-
TABLE I.-Pooled Control Datafor Mouse Leukaemia P-388
First cycle
" Dose" n r q = n
8 . 95 88 . 0926 . +0-40 . 281 . +0-015
4 . 164 114 0-695 +0-10 . 546 . -0*026
2 . 164 77 . 0-470 . -0-20 . 394 . +0O003
1 125 27 0-216 . -0 50 . 179 . -0 104
Snw = 1400
Snw# = - 27-415
- =- 0020
tion of the separate results of the assays during this period showed no evidence
of trend, and no more than the expected variability about the mean: hence it
is legitimate to pool the results of all these assays.
The first three columns are filled in from the experimental data. For such
large groups of assay animals it is just worth while to calculate q, the proportion
responding, to three decimal places: two places would more often be appro-
priate.
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The Y column must now be filled in. A poor choice of Y's from which to
start will not influence the final answer, but will necessitate extra iterative cycles.
In Appendix B, Table I, values of Y are given for various values of Q, the propor-
tion of animals theoretically expected to respond. One value in the Y columni
can usually be filled in from consideration of the observed proportion of responises
in conjunction with this table. In the example, the Y value for a dose " of
2 cells was filled in first, since Q _ 047 corresponds to Y - -0 20. The dilution
ratio here is uniformly 2, and log 2 -030, so that the remaining Y's can be
filled in at once, to two decimal places. If the dilution ratios had not been
constant, it might have been helpful at this stage to tabulate the logarithms of
the " doses " on the extreme left of the table.
For each entry in the nw column, n has already been tabulated and w is found
in Appendix B, Table II, against the appropriate value of Y. Thus the first
entry is given by nw 95 x 2495 ' 281 : three significant figures are ample.
The E values are formed from
5 -0 +qA
taking 00 and A from Appendix B, Table II, for the appropriate value of Y.
Thusthefirstq0is 1.959 +0926 x 2d131= +(0015.
Snw is formed as the sum of the values in the nw column; aind Snwo as the
algebraic sum of the products of the corresponding niumbers in the nw and l
columns.
Obviously 4 is small, inidicating a fortunate choice of iniitial Y's. anid there is
no need for another cycle. If 5 had been numerically larger than 0-04, it wouild
have been reasonable to compute another cycle. Equally obviously oni inspec-
tion, the data are internally consistent, but if an iniconsistency x2 is computed its
value is found as 2-30, which with three degrees of freedom shows no iniconi-
sistency.
The logarithm of the ratio
reproductively initact
morphologically typical
cells in this populationi of mouse leukaemia cells (log E) canl now- be estimated
b)y:
log E Y - + log "dose"
usinig anyv rowr in the table. The rows should agree, apart from roundinig errors.
and in this case usinlg the second row we have
log E 4- 0.10( 0.020 - 0.602 0-522 ---478
The stanidard error of log E is V(I/Snw), hence 95 per cent confidence limits
can be placed at:
log E -196 log E I J 96
or in this case at i-424, T.532. The conclusion is that the proportioni of repro-
ductively intact cells in this population is estimated as 10'4 478 30 per cent, with
95 per cent confidenice that the true value lies betweein 34 per cent and 26- per
cent.
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ASSAY DESIGN-
The variance of estimate of log E resulting from an assay such as we are coIn-
sidering is given by the reciprocal of Snw, the sum of the weights. Clearly the
best assay design will be that which gives the largest Snw for the fewest assay
animals. From this point of view, each animal may be thought of as contri-
buting ani amount (w) to the precision of the assay, and this amount depends on
Y ; that is on the actual number ofreproductively intact cells given to the animal.
Inspectioni of Appendix B, Table II, shows that w is at its maximum when
Y + 0 2: that is, when the mean number of intact cells per "' dose " is about
l 6. and the response rate about 80 per cent.
The pooled control data analysed above will serve to illustrate this argument.
We note that it is, in general, a well-designed assay, for no animals have been
tested at " doses" with very low weighting coefficients. However, the group of
125 mice given a "dose " of one morphologically typical tumour cell per mouse
contribute 179) to Snw; and only 54 mice tested at a "' dose " of 4 cells would
have contributed the same amount. Even here, then, a slight change in the
dlesign of the assay would have obtained the same precision with a savingf of
71 mice.
If completely reliable advance information were available on the result to be
expected from an assay, the assay would naturally be designed with only one
glroup of assay animals. Every available animal would then be given a " dose"
that was expected to contain on average 1 6 reproductively intact cells, and if all
went well each assay animal would contribute the maximum to Snw. This, of
course, is not a practical design for an assay, since with such a design inaccuracies
in the advance information can have a disastrous effect on the precision of the
assay, and even on the possibility of forming an estimate of log E at all. For
example, if the initial estimate were pessimistic by a factor of two, the " dose"
given would contain on average 3-2 reproductively intact cells, and with a group
of 20 aniimals there would be a 43 per cent risk that all animals would develop
ttumours.
Thus two factors affect the design of a practical assay; the desirability of
economy of assay animals, and the need for insurance against inaccurate advance
iniformation. If the advance information is unreliable, a wide range of " doses "
must be used to provide insurance; if the advance information is reliable, such
nisurance is merely wasteful.
In radiobiological work the proportion of cells treated in the same way which
i-etain their reproductive integrity is expected to remain constant from one experi-
ment to the next. If this condition is not fulfilled, then either the experiment
has miscarried, or else any information that can be gleaned from it is not radio-
biological. If it may be assumed that repeated assays will measure the same
reproductively intact proportioni, then the assays can be planined to give at each
stage the appropriate amount of insurance.
Consider the case where the advance information has only the status of a
wild guess. AIn assav design specifying groups of four animals. and " doses
of morphologically typical cells spaced by factors of eight, is appropriate. With
four such groups of assay animals, the " doses " should be planned so that if the
initial guess is correct the central two groups will receive I and 2 intact cells per
aniimal. Now if the initial guess is so wrong that the lowest dose " containis
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more than 0-64 intact cells, then there will be a greater risk than 5 per cent that
all the animals in the lowest group will succumb.
If all the animals in the lowest group do succumb, the assay will be unin-
formative, for even if some of the animals given higher doses escape, this will
merely serve to cast suspicion on the execution of the assay, and it is more likely
that every animal in the assay will succumb so that no estimate will be possible.
Similarly if the initial guess is so wrong that the highest group receives less than
0 75 cells per animal, there will be a greater risk than 5 per cent that none of the
animals in the highest group will succumb, again rendering the assay uninforma-
tive. If we wish to be at least 95 per cent certain that the assay will be informa-
tive, the initial guess must be within a range which extends approximately from
1/21st of the true value to 21 times it, and in this sense the insurance provided
by this assay design extends from 21 times the initial guess to 1/21st of it. In
the same way an assay design with five groups, each of four assay animals, and
the " doses " again spaced by factors of eight, will give insurance from 1/59th of
the initial guess to 59 times it: but here the central group should be given a
"dose " which will contain 0-7 cells if the initial guess is correct.
Such preliminary assays pay a heavy price for insurance, since the average
contribution to Snw of each assay animal will be less than 30 per cent of the
maximum possible. Hence no very accurate estimate may be expected, and to
increase the number of animals in each group above four would be imprudent.
It will be more economical to use any extra animals in a subsequent, more efficient
assay, which can have less insurance. The result of such a preliminary assay as
these two will have 95 per cent confidence limits extending from one-third to
thrice the estimate approximately.
From the results of such a preliminary assay, a second assay of cells treated
in the same way can be planned. A design using three groups of animals, with
" doses " separated by factors of four, and estimated (from the result of the
preliminary assay) to contain , 1 and 4 reproductively intact cells per " dose"
would be appropriate. This design would have an entirely adequate amount of
insurance, and the average contribution to Snw of the assay animals would be
approximately 50 per cent of the maximum possible. Groups of less than five
animals are undesirable, groups of more than ten are usually impracticable. If
groups of six animals are used in this second assay, and ifthe result is compatible
with that obtained in the preliminary assay, it will be possible to pool the two
assays, and derive an estimate of the proportion of reproductively intact cells
with confidence limits at about 53 per cent and 188 per cent of the estimate.
If further precision is desirable beyond this stage, it would be reasonable to
reduce the amount of insurance still further. A design with three groups of
assay animals given " doses " estimated on the basis of all available evidence to
contain 1, 1 and 2 reproductively intact cells would be expected to yield an
average contribution to Snw from the assay animals of between 60 per cent and
75 per cent of the maximum possible. Designs with even less insurance may be
regarded as too imprudent for most situations.
The combination of estimates
When two or more assays have been made of the proportion of reproductively
intact cells among cells treated in the same way, the problem arises of combining
the information from both assays. The two estimates could be formed, and a
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weighted mean obtained using the Snw's as weights, but a better procedure is to
pool the actual data, as if they were obtained in a single assay. If now the
inconsistency x2 is significantly large, this may mean that the component assays
are incompatible, in which case the pooling would not be legitimate. The point
can be investigated by analysing the component assays separately: if they are
internally consistent (but incompatible) reasons should be sought for this. If,
however, one or more of the component assays are themselves internally incon-
sistent, they may be rejected and an attempt made to pool the remainder.
SUMMARY AND CONCLUSIONS
The statistical analysis of assays in vivo of the proportion of reproductively
intact cells contained in tumour cell suspensions is discussed, and a method of
analysis presented. This method of analysis, slightly modified from the method
of Finney (1952), allows the internal consistency of the assay to be checked, and
the standard error of the final estimate to be computed.
Applications to the design of such assays are made, distinguishing cases where
advance information is unreliable, and the assay must allow for a wide range of
possible outcomes, from cases where reliable advance information permits an
assay design which will give higher precision from the minimum number of assay
animals.
Thanks are due to Dr. Basil Shepstone for programming the tables of Ap-
pendix B for the Oxford University Digital Computer, to Dr. D. J. Finney,
F.R.S., for helpful discussion, to Dr. J. R. Andrews for permission to use experi-
mental results obtained jointly, and to Dr. Frank Ellis, Director of the Radio-
therapy Department for enthusiastic encouragement.
R. J. B. is a Helen Hay Whitney Fellow in Radiobiology at Oxford University.
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APPENDIX A
Reed and Muench (1938) proposed a rapid method for the statistical analysis
of quantal data that has been extensively and uncritically applied to assays of
the reproductive integrity of tumour cells. In this context, the only virtue of the
Reed-Muench method is its disarming computational simplicity: its defects
include an inappropriate theoretical background (see Finney (1952), for discus-9E. H. PORTER AND R. J. BERRY
sioIn), a total absenice of validity tests and of estimates of precision, a tendency to
bias, and (most serious ofall) the compulsion to use an inefficient assay design.
The Reed-Mueiich method is a quick and simple one for the estimation of a
50 per cent effective dose, for use when a wide range of regularly spaced doses
(extending from 0 per cent to 100 per cent effective) have been tested, each oIn
the same number of assay animals. The numbers of animals responding to the
different doses are summed from low dose to high; and the numbers failing to
respond are summed from high to low. The 50 per cent effective dose is estimated
from these sums, either as the dose for which the two sums are equal, or by inter-
polatioli. The argument is that an animal which responds to a low dose would
certainly have responded had the dose been higher ; one which fails to respond
to a high dose would not have responded had the dose been smaller.
An example of the method is given in Appendix A, Table I, and it will be
seeni that the process of forming the sums involves the tacit assumptions that
had a group of animals been given a higher " dose " than was actually tested, all
wsould have succumbed, and that had a group been given a lower " dose ", all
would have survived. An estimate of the TD50 is formed bv graphical inter-
polation, usinlg the ratios
S(+) +S( )
iin this case it is 7500 cells.
Reed and Muench recommended interpolation in the logarithms of the doses,
but in radiobiological work the custom has arisen of interpolating directly in the
doses ". This is somewhat less satisfactory than Reed anid Muench's own
procedure.
No way of assessing the precision of such a Reed-Muench estimate is known
except for the case of an underlying logistic distribution, where Pizzi (1950) has
proposed a useful approximation. This approximation is not unreasonable, for
the curve of Q against log-dose differs little from the logistic form. No validity
test (test of internal consistency) is available in the Reed-Muench method.
It may readily be seen that the Reed-Muench estimate is only unbiased if the
chance of a response varies symmetrically about 50 per cent when plotted against
dose. This can be demonstrated by applying the method to figures conforming
to aIn asymmetric distribution. The sigmoid of a Poisson distribution is not
symmetrical about Q- 0 5 (i.e. about x = loge 2), whether Q is plotted against x
or against the logarithm of x. Consequently the Reed-Muench method must
introduce a bias into the estimate; but when the number of animals per group is
small, and the range of " doses " wide. this inherent bias is negligible.
When, however, the range of " doses " is narrow (as in the example given) a
serious bias canl arise from the use of the Reed-Muench method. This bias is
small when the centre of the range of ' doses " used is near to the true 50 per cenit
point; but if the centre of the assay is moved away from the true 50 per cent
point, the bias increases rapidly. In the example givein, the bias entering in this
way amounts to about 20 per cent.
If the Reed-Muench method of analysis is to be used, the design of the assav
must be such as to avoid this serious source of bias. That is, the experimenter
must plan his assay for a wide range of " doses ", so as to ensure as far as possible
that the highest " dose " will produce 100 per cent responses, the lowest " dose "
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0 per cent. This is, of course, quite contrary to the priniciples of economical assay
design discussed above, for where advance information is available a more effi-
cient assay design is possible. This conlpulsorv waste of assay animals is the
major defect of the Reed-Muench method.
Appendix A, Table J. AInoxic mouse leukaemia cells P-3X8, after
3000 rads (250 kv)
Mlice Mice
l sp)ondinlg sulrviving S(+)
"Dose (+) S() S(-) S(-+S(
12,801) 3 3 8 3 8
6,400( 3 3 :i . 6
3200 2 . 4 . 2 10
1,600 . 6 0 1i 0
APPENDIX B
Appendix B, Table I
Q 0-00 0(01 0-02 0 03 0-04 0-005 006 0a07 008 0 0.09
.00 - 2 -2000 -1 70 -1 a: -1-39 -1 29 -1-21 -1 14 --l-X -1-)03
0.1 0-(O 98 -0 93 - 0 89 -0-86 -0 82 -0 79 -0 76 -0- 73 -070 -0 68
0-2 0 O 65 06 () t 3 -0 61 0 58 0 56 0 54 00 0 52 )0 -0( 48 0 47
0 3 (0 45 (0 43 -0 41 040 0O( 38 0 37 0 35 -0 34 0-32 0 31
0-4 -0O-29 -O- 28 -026 -O 25 -0-24 -0-22 -0221 -0-20 -0 18 --0(17
05. -0-16 l 0-15 0-013 -012 -0) l -01 0-10 009 -0-07 -006 -0 05
0 6 --0*04 -0 03 -001 0*00 (-0 0l 02 * - 0*3 -005 L-0(06 t-007
0 7 -t 008 0 09 -O*11 L0 12 0*13 -O 14 - 015 i-017 A 018 tO* 9
0-8 0-(-021 022 023 +(- 25 4-0 26 0-28 0-29) -0-31 0 33 +0O34
09 -0-36 3 - 40 0- 43 -0 45 (048 -051 0- 55 0* - 0 66
This table gives values of Y, the logarithm of the average iiumber of repro-
ductively intact cells per dose". Y is given for different values of Q, the
theoretically expected proportion of animals that should responid to the cor-
responding dose ". The function tabulated is:
Y log10 loge (1 Q)}
NVote to Appendix B. Table II
This table gives, for different values of Y, the correspondinig values of 0, A,
51 anid w. For the mathematical and logical details of the theory, the reader is
referred to Finniey (1952), who develops a method in which Y is defined in terms
of niatural logarithms, and the non-occurrence of a tumour is taken formally as a
response
The method presented here, to which this table is appropriate. differs from
Fininiey's method in its use of a Y defined in terms of common logarithms, and in
the use of the occurrence of a tumour as a response. These changes make the
computations more convenient. but complicate the algebraic formulatioin of
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the functions tabulated. These are:
1 -exp{1OY}
loge 10 X 10l
A exp {10Y}
loge 10 X 10"
1
loge 10 X lOY
(loge 10)2 X 102Y
exp {l0"}-1
The Oxford University Ferranti Mercury computer
table, which it did in four minutes.
was used to compute the
Appendix B, Table II
y
1-18
1-16
1-14
1-12
1-10
1-08
1-06
1-04
1-02
1-00
0-98
0-96
0-94
0-92
0-90
0-88
0-86
0-84
0-82
0-80
0-78
0-76
0-74
0-72
0-70
0-68
0-66
0-64
0-62
0-60
0-58
0-56
0-54
0-52
0-50
#0
-107,422- 78686
-56,917 -86120
-31,096- 80798
-17,494- 39636
-10,121- 05267
-6,013- 80093
-3,665- 61503
-2,289 39292
- 1,463- 50002
-956- 55226
-638-60567
-435- 05966
-302-17519
-213- 78726
-153- 94062
-112- 72593
-83-88009
-63-37786
-48-59056
-37-77515
-29-75886
-23-74157
-19-17004
-15-65685
-1- *92740
- 10-78473
-9- 08605
-7- 72666
-6-62907
-5. 73533
-5-00171
-4-39491
-3- 88936
-3- 46525
-3- 10713
A
107,422- 81567
56,917- 89147
31,096- 83947
17,494- 42932
10,121- 08709
6,013- 83706
3,665- 65284
2,289 -43253
1,463- 54150
956- 59569
638- 65115
435- 10728
302- 22506
213- 83947
153-99530
112- 78318
83- 94004
63-44064
48- 65630
37-84398
29- 83094
23-81704
19-24907
15- 73960
13-01405
10- 87547
9-18106
7-82615
6-73325
5-84442
5- 11594
4-51453
4-01461
3-59640
3-24447
#1
0-02869
0-03005
0-03146
0-03294
0-03450
0- 03612
0-03783
0-03961
0- 04147
0-04343
0- 04548
0- 04762
0-04986
0-05921
0-05467
0-05725
0-05995
0-06277
0-06573
0-06883
0-07207
0-07547
0-07903
0-08275
0-08665
0-09074
0-09501
0- 09949
0-10418
0- 10909
0-11423
0- 11961
0- 12525
0- 13115
0-13734
w
0-00032
0-00058
0-00102
0-00174
0-00286
0-00460
0-00721
0-01103
0- 01647
0- 02407
0-03443
0- 04827
0- 06637
0- 08958
0-11881
0- 15495
0- 19886
0- 25135
0- 31309
0- 38460
0-46623
0- 55809
0- 66007
0- 77181
0- 89270
1-02189
1-15835
1-30084
1-44798
1-59830
1- 75024
1-90224
2-05276
2- 20030
2- 34345
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Appenditx B, Table II (continued)
Y 00 A 01 w
0*48 -29*80287 2*94668 0-14381 2*48092
0 46 -2-54283 ;-*69341 0-15059 2-61155
0 44 -2-31934 2 47703 0-15768 2-73433
0 42 -2-12626 2X29137 0 1K6511 2-84840
0 40 1 ! 95859 2 13149 0.17290 2 95306
0-38 - 1 -81231 1 -99335 0- 18104 3 04778
0 36 -1-68410 1-87368 C*18958 3-13218
0 34 - 1 57126 1-76977 0-19851 3-20603
0 32 - 1 -47153 1 -67940 0 20787 3o26923
0 30 -1-38306 1-60072 0-21766 3-32181
0 28 -1-30428 1-53220 0 2-2792 3 36i39-0
0 26 - 1 -23389 1 -47255 0 23866 3* 39578
0-24 - 1 -17079 1 -42070 0* 24991 3*41773
0 22 - 1 -11404 1*37573 0-26169 3*43015
0 20 -1-06287 1-33689 0 27402 3-43350
0 18 - 1 -01658 1 -30351 0 28694 3 42827
0-16 -0-97460 1-27506 0-30046 3-41498
0-14 -0-93644 1-25106 0-31462 3-39419
0 12 -0-90166 1-23111 0 32945 3-36645
0 10 -0-86989 1-21487 0 34497 3-33234
0 08 -0 84082 1 20-205 0-36123 3-29242
0-06 -0-81414 1-19240 0-37825 3-24724
0-04 -0 78963 1-18571 0 39608 3-19737
0 02 -0 76706 1-18181 0-41475 3-14331
0 00 -0 74624 1- 18053 0 43429 3-08558
-0-02 -0-72701 1-18177 0 45476 3-00467
-0 04 -0-'0921 1 18540 0- 47619 2 96]03
-0-06 -0-69271 1 19135 0-49864 2-89510
-0 08 -0 67740 1-19954 0-52214 2-82728
-0 10 -0-66318 1-2-0992 0 54674 2-75795
-0-12 -0 64994 1-22245 0-57251 2-68748
-0-14 -0 63760 1-23709 6, 59949 2-61617
-0- 16 -0 62610 1-25384 0- 62775 2-54434
-0-18 -0-61535 1-27268 0 65733 2-47225
-0 20 -0-60531. 1-29362 0-68831 2-40016
-0-22 -0-59591 1-31666 0-72075 2-32829
-0 24 -0-58710 1-34182 0 75472 2-25684
-0-26 -0-57885 1 -36914 0-79029 2 18599
-0-28 -0- 57111 1 -39864 0-82753 2- 11592
-0 30 -0-56383 1-43037 0 86653 2-04675
-0 32 -0-55700 1*46437 0 90737 1-97861
-0-34 -0-55057 1*50070 0-95013 1*911611
-0 36 -0-54452 1-53943 0-99491 1-84587
-0 38 -0- 53882 1*58062 1*04180 1*78143
-0 40 -0 53345 1-62435S 1 09090 1-71838
-0 42 -0-52839 l1fi7070 1-14231 1 65677
-0-44 --0-52361 1-71976 1-19615 1-59664
-0 46 -0-51910 1-77162 1*25252 1-53803
-0-48 -0-5a1484 1-82639 1-31155 1-48096
-0 50 --0-51081 1-88417 1-37336 1-42546
-0-52 -0 50700 1 94509 1-43808 1-37153
-0-54 -0 50340 2-00926 1-50586 1-31917
-0-56 -0-49999 2-07682 1-57683 1-26839
-0-58 -0-49677 2-14791 1-65114 1-21917
-0 60 -0-49371 2-22267 1 #72896 1#17151E. H. PORTER AND R. J. BERRY
Appendix B, Table II (continued)
Y 00 A ol w
-0-62 -0-49081 2-30125 1-81044 1-12538
-0-64 -0-48807 2-38383 1-89576 1-08078
-0-66 -048546 247057 1-98511 1-03767
-0-68 -0-48299 2-56166 2-07866 0-99603
-0-70 -0-48065 2-65728 2-17663 0-95584
-0-72 -0-47843 2-75764 2-27921 0-91706
-0-74 -0-47632 2-86294 2-38663 0-87967
-0-76 -0-47431 2-97342 2-49910 0-84362
-0-78 -0-47241 3-08929 2-61688 0-80890
-0-80 -0-47060 3-21082 2-74021 0-77546
-0-82 -0-46888 3-33824 2-86936 0-74328
-0-84 -0-46725 3-47183 3-00458 0-71231
-0-86 -0-46570 3-61188 3-14619 0-68251
-0-88 -0-46422 3-75868 3-29446 0-65387
-0-90 -0-46282 3-91254 3-44972 0-62634
-0-92 -0-46148 4-07378 3-61230 0-59988
-0-94 -0-46021 4-24276 3-78255 0-57446
-0-96 -0- 45900 4-41981 3-96081 0-55005
-0-98 -0-45785 4-60533 4-14748 0-52662
-1-00 -0-45675 4-79970 4-34295 0-50412
-1-02 --0-45571 5-00333 4-54762 0-48254
-1-04 -0-45471 5-21666 4-76194 0-46182
-1-06 -0-45377 5-44014 4-98637 0-44196
-1-08 -0-45287 5-67424 5-22137 0-42291
-1-10 -0-45201 5-91945 5-46744 0-40464
-1-12 -0-45119 6-17631 5-72512 0-38713
-1-14 -0-45041 6-44535 5-99493 0-37034
-1-16 -0-44967 6-72714 6-27747 0-35426
- 1-18 -0-44896 7-02228 6-57331 0-33885
-1-20 -0-44829 7-33139 6-88310 0-32408
-1-22 -0-44765 7-65514 7-20750 0-30994
-1-24 -0-44703 7-99421 7-54717 0-29640
-1-26 -0-44645 8-34931 7-90286 0-28343
-1-28 -0-44589 8-72121 8-27531 0-27101
-1-30 -0-44536 9-11068 8-66532 0-25912
-tI'32 -0-44486 9-51856 9-07370 0-24774
-1-34 -0-44437 9-94570 9-50133 0-23685
-1-36 -0-44391 10-39303 9-94911 0-22642
-1-38 -0-44347 10-86148 10-41800 0-21645
-1-40 -0-44306 11-35204 10-90899 0-20690
-1-42 -0-44266 11-86577 11-42311 0-19776
-1-44 -0-44227 12-40374 11-96147 0-18903
-1-46 -0-44191 12-96710 12-52519 0-18067
-1-48 -0-44156 13-55705 13-11549 0-17267
-1-50 -0-44123 14-17484 13-73360 0-16502
-1-52 -0-44092 14-82176 14-38085 0-15771
- 1-54 -0-44062 15-49921 15-05859 0-15071
-1-56 -0-44033 16-20861 15-76828 0-14402
-1-58 -0-44006 16-95148 16-51142 0-13763
- 1-60 -0-43979 17-72937 17-28958 0-13151
-1-62 -0-43955 18-54396 18-10441 0-12566
-1-64 -0-43931 19-39696 18-95765 0-12007
-1-66 -0-43908 20-29017 19-85109 0-11473
-1-68 -0-43886 21-22551 20-78665 0-10962
-1-70 -0-43866 22-20495 21-76629 0-10473
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Appendix B, Table II (continued)
Y 00 A 01 w
- 1 -72 -0o*43846 23-23057 22-79211 0- 10007
- 1 -74 -0-43827 24-30454 23-86627 0-09560
- 1 -76 -0-43809 25-42914 24-99105 0-09134
- 1 -78 -0*43792 26- 60676 26- 16884 0-08726
-1 *80 -0-43775 -47-83989 27-40214 0- 08337
-1 -82 -0-43760 -99*13116 28*69356 0*07964
-1 -84 -0*43745 30-48330 30-04.585 0-07608
- 1 -86 -0- 43731 31 *89917 31 *46187 0 07268
- 1 -88 -0 43717 33-38179 32-94462 0-06943
- 1.-90 -0- 43704 34- 93429 34 49725 0 06633
- 1 -92 -0+43692 36-55997 36-12306 0-06336
- 1 *94 --0-43680 38-26228 37*82548 0-06053
- 1 -96 -0- 43668 40- 04483 39-60814 0 05782
- 1 -98 -0-43658 41 -91140 41 -47482 0-05523
-2*00 -0- 43647 43-86594 43-42947 0*059075
-2-02 -0-43637 45-91261 45-47623 0-05039
-2-04 -0-43628 48- 05574 47-61946 0- 04813
-- 2-06 -0 43619 50 29989 49- 86370 0 04598
-2-08 -0*43611 52- 64981 52* 21370 0-04392
-29-10 -0-4.3602 55- 11048 54-67446 0-04195
-2 '- 12 -0-43595 57-68713 57-25119 0-04007
-2-14 -0o*43587 60-38522 .59 - 4935 0@03827
-2S-16 -0-43580 63-21048 62>-77468 0-03655
-2- 18 -0-43573 66- 16889 65-73315 0-03491
-2 20 -0- 43567 69-26673 68- 83106 0* 03335
- 2*22 -0- 43561 72*51057 72-07497 0-03185
- -)- 24 ~-- 0 43555 7.5- 90730 75- 77 0- 03042
-2-2*6 -0- 43549 79-*4fi412 7'9*02863 0-02906
-2-*28 -0- 43544 83-18857 892-75313 0-02775
-2- 30 -0- 43538 87 -08855 86-65317 0 02651
-2-32 -0-43534 91 -17234 90- 73701 0-02532
-2-34 -0-43529 95-448.59 95-01331 0*02418
-2-36 -0-43524 99-92639 99-49114 0-02309
-2-38 -0-43520 104-61522 104- 18002 0-02206
-2-40 -0- 43516 109-52503 109-08987 0* 02107
-2-42 -0-43512 114-666244 114-23112 0-02012
-2-44 -0- 43508 120-04975 119-61466 0- 01922
-2-*46 -0o*43505 125-68697 125-251990 0-01835
-2-48 -0- 43501 131 -58988 131 -15486 0- 01753
-2-50 -0- 43498 137 -77099 137 -33600 0* 01674
-2-52 -0- 43495 144- 24340 1436-80845 0- 01599
-2-54 -0-43492 1.51 -02085 150 - 58593 0-01527
-2-*56 -0- 43489 158-11772 157 -68282 0-01458
-2-958 -0-43487 165-54905 165-11418 0-01393
-2-60 -0-43484 173-33062 172-89578 0-01330
-2-*62 -0-43482 181 -47892 181 -04410 0-01270
-*2*64 -0- 43479 190- 01124 18.9- 57645 0- 01213
-2-66- -0-43477 198-94567 198-51090 0-011.59
-2-68 -0-43475 2@08-30118 207 -86643 0-01107
- 2 - 70 -0-43473 218-09761 217*66288 0-01057
-2*72 -0-43471 228-3%5572 227 -929101 0-01009
-2-74 -0-43469 239-09728 238-66259 0-00964
-2-76 -0-43467 250-34509 249-91041 0-00921
-2-78 -0-43465 262- 12297 0,61-68832 0-00879
-2-80 -0- 43464 274- 45594 274- 02130 0- 00840